Nuclear Medicine: Page 125

Blue Earth secures $28M in venture capital

By AuntMinnie.com staff writers

Blue Earth Diagnostics has received $27.9 million (25.4 million euros) in capital from U.K. venture fund Syncona Partners.

July 22, 2015

Lilly touts latest study on florbetapir's efficacy

By AuntMinnie.com staff writers

At this week's Alzheimer's Association International Conference in Washington, DC, Eli Lilly is touting a new study that shows how PET amyloid imaging with its florbetapir radiopharmaceutical (Amyvid) can change the diagnosis and management of patients with Alzheimer's disease.

July 22, 2015

SPECT distinguishes TBI, PTSD in broad population

By Wayne Forrest

SPECT is once again showing its value by distinguishing the fine line between post-traumatic stress disorder (PTSD) and traumatic brain injury (TBI) in nonmilitary patients, which should lead to better treatment for the disorders.

July 19, 2015

Dilon touts MBI for invasive lobular carcinoma

By AuntMinnie.com staff writers

Molecular breast imaging (MBI) developer Dilon Diagnostics is highlighting a study that suggests MBI is a sensitive technique for diagnosing invasive lobular carcinoma, a breast cancer that tends to be difficult to detect.

July 16, 2015

Brain SPECT shows improvement after cocaine users abstain

By Wayne Forrest

Dysfunction in the prefrontal cortex region of the brain caused by excessive cocaine use may be reversed to some degree after more than one month of abstinence, researchers from Uruguay have found. Their findings are promising news for rehabilitation efforts, but the group cautioned that some brain dysfunction does appear to remain.

July 9, 2015

Blue Earth gets orphan drug status

By AuntMinnie.com staff writers

Blue Earth Diagnostics has received two orphan drug designations for its F-18 fluciclovine radiopharmaceutical for diagnosing glioma.

July 7, 2015

PET suggests link between anxious parents, children

By AuntMinnie.com staff writers

PET imaging of rhesus monkeys has shown how an overactive circuit in three regions of the brain may contribute to parent-to-child transmission of anxiety and depression. The findings were published online July 6 in the Proceedings of the National Academy of Sciences.

July 7, 2015

Isologic opens Toronto cyclotron facility

By AuntMinnie.com staff writers

Isologic Innovative Radiopharmaceuticals has opened a new cyclotron and radiopharmaceutical manufacturing facility at Toronto's Sunnybrook Health Sciences Centre.

July 7, 2015

Global isotope market could reach $7B by 2020

By AuntMinnie.com staff writers

Widespread use of radiopharmaceutical isotopes with diagnostic equipment such as PET and SPECT systems could buoy the global nuclear medicine/radiopharmaceutical market to $7 billion by the end of the decade.

July 7, 2015

Navidea touts Manocept clinical trial

By AuntMinnie.com staff writers

Radiopharmaceutical developer Navidea Biopharmaceuticals and its Macrophage Therapeutics subsidiary are touting the results of their Manocept clinical trial for Kaposi's sarcoma.

July 1, 2015

AAA signs Fuji as distributor in Japan

By AuntMinnie.com staff writers

French molecular imaging firm Advanced Accelerator Applications (AAA) has signed a distribution deal for its Lutathera radiopharmaceutical with Fujifilm RI Pharma in Japan.

June 30, 2015

Lantheus sets IPO stock price

By AuntMinnie.com staff writers

Lantheus Medical Imaging's parent company, Lantheus Holdings, has set the price for its stock at $6 per share for its initial public offering (IPO) on the Nasdaq stock exchange.

June 24, 2015

Previous Page

Page 125 of 438

Next Page